SKB103
/ Sichuan Kelun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 11, 2026
SKB103 for Injection in Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=277 | Not yet recruiting | Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
New P1/2 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1